Ani Pharmaceuticals (ANIP) Net Cash Flow (QoQ) (2010 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.52% |
| Mar 31, 2026 | 4.55% |
| Dec 31, 2025 | -45.01% |
| Sep 30, 2025 | -34.13% |
| Jun 30, 2025 | 1,181.85% |
| Mar 31, 2025 | 1,826.10% |
| Dec 31, 2024 | 100.29% |
| Sep 30, 2024 | -925.31% |
| Jun 30, 2024 | 54.00% |
| Mar 31, 2024 | -73.34% |
| Dec 31, 2023 | -10.61% |
| Sep 30, 2023 | -66.61% |
| Jun 30, 2023 | 546.90% |
| Mar 31, 2023 | 280.41% |
| Dec 31, 2022 | -13.35% |
| Sep 30, 2022 | 47.49% |
| Jun 30, 2022 | 42.18% |
| Mar 31, 2022 | -127.50% |
| Dec 31, 2021 | 1,044.22% |
| Sep 30, 2021 | -1,010.60% |